Extrarenal Vitamin D Hydroxylase Expression and Activity in Normal and Malignant Cells: Modification of Expression by Epigenetic Mechanisms and Dietary Substances
- 28 June 2008
- journal article
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 65 (suppl_2) , S108-S112
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Folate and Risk of Breast Cancer: A Meta-analysisJNCI: Journal of the National Cancer Institute, 2007
- Calcium plus Vitamin D Supplementation and the Risk of Colorectal CancerNew England Journal of Medicine, 2006
- Vitamin D and calcium deficits predispose for multiple chronic diseasesEuropean Journal of Clinical Investigation, 2005
- Epigenetic regulation of Vitamin D hydroxylase expression and activity in normal and malignant human prostate cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- 25-Hydroxy-Vitamin D Metabolism in Human Colon Cancer Cells during Tumor ProgressionBiochemical and Biophysical Research Communications, 2001
- 25-Hydroxyvitamin D3-1α-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesisSteroids, 2001
- Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: Expression of 25-hydroxyvitamin D3-1α-hydroxylase activity and regulation of sidechain metabolismThe Journal of Steroid Biochemistry and Molecular Biology, 1997
- BRIEF COMMUNICATION: Growth Control of Human Colon Cancer Cells by Vitamin D and Calcium In VitroJNCI: Journal of the National Cancer Institute, 1992
- SERUM 25-HYDROXYVITAMIN D AND COLON CANCER: EIGHT-YEAR PROSPECTIVE STUDYThe Lancet, 1989
- DIETARY VITAMIN D AND CALCIUM AND RISK OF COLORECTAL CANCER: A 19-YEAR PROSPECTIVE STUDY IN MENThe Lancet, 1985